GlassScriptPhysician profile
Jeffery B Dattilo
NPI 1326022039
$3,520.07
in general payments reported to CMS, 2019-2025
17 companies · $346 in 2025
The $346 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,502 · 2020: $214 · 2021: $400 · 2022: $128 · 2023: $492 · 2024: $438 · 2025: $346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,276.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $966.34 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $924.89 | 2019-2025 | Gore Synecor Biomaterial, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Excluder Aaa Endoprosthesis |
| Medtronic, INC. | $496.15 | 2021-2024 | Endurant Iis, Ligasure |
| Silk Road Medical, INC. | $326.60 | 2019-2021 | |
| Abbott Laboratories | $305.43 | 2023-2024 | Esprit, Jeti |
| Cook Medical LLC | $185.06 | 2019-2023 | Zilver Ptx |
| Lemaitre Vascular, INC. | $67.08 | 2019 | |
| Innovation Technologies INC | $64.46 | 2025 | Irrisept |
| Inari Medical, INC. | $37.12 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Smith+Nephew, INC. | $27.96 | 2023-2024 | Renasys Touch, Renasys Go V2 Home, Pico 14 |
| Stryker Corporation | $20.27 | 2023 | Spy-Phi System |
| Penumbra, INC. | $18.93 | 2022 | |
| Boston Scientific Corporation | $17.26 | 2020 | |
| Ethicon US, LLC | $17.08 | 2021 | |
| Kci USA, INC. | $16.01 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endogastric Solutions, INC | $15.54 | 2023 | Esophyx |
| Pfizer INC. | $13.89 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffery Dattilo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.